Shares of Quest PharmaTech Inc. (CVE:QPT – Get Free Report) traded up 40% during mid-day trading on Thursday . The stock traded as high as C$0.04 and last traded at C$0.04. 105,000 shares traded hands during mid-day trading, an increase of 54% from the average session volume of 67,993 shares. The stock had previously closed at C$0.03.
Quest PharmaTech Price Performance
The stock has a 50-day moving average of C$0.02 and a 200 day moving average of C$0.03. The company has a market capitalization of C$4.23 million, a PE ratio of -1.25 and a beta of 0.09. The company has a quick ratio of 0.52, a current ratio of 0.54 and a debt-to-equity ratio of 4.49.
Quest PharmaTech (CVE:QPT – Get Free Report) last announced its earnings results on Friday, June 28th. The company reported C($0.01) earnings per share (EPS) for the quarter.
About Quest PharmaTech
Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer.
Featured Articles
- Five stocks we like better than Quest PharmaTech
- What Is WallStreetBets and What Stocks Are They Targeting?
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- What is a Bond Market Holiday? How to Invest and Trade
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Quest PharmaTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest PharmaTech and related companies with MarketBeat.com's FREE daily email newsletter.
